
Sign up to save your podcasts
Or


Frank Holland and the Investment Committee discuss if today’s jobs report gives the Fed the greenlight to resume raising rates. Plus, a strong first months for the semi stocks. The panel debates what’s ahead for the chips in the second half of the year. Bullish calls out on Ford, GM and Tesla. And, the Chart of the Day is Biogen, as it gets FDA approval for its Alzheimer’s treatment.
Investment Committee Disclosures
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
By CNBC4.5
344344 ratings
Frank Holland and the Investment Committee discuss if today’s jobs report gives the Fed the greenlight to resume raising rates. Plus, a strong first months for the semi stocks. The panel debates what’s ahead for the chips in the second half of the year. Bullish calls out on Ford, GM and Tesla. And, the Chart of the Day is Biogen, as it gets FDA approval for its Alzheimer’s treatment.
Investment Committee Disclosures
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

4,093 Listeners

3,239 Listeners

1,366 Listeners

239 Listeners

151 Listeners

523 Listeners

325 Listeners

67 Listeners

153 Listeners

33 Listeners

45 Listeners

2,156 Listeners

596 Listeners

5 Listeners

563 Listeners

20 Listeners

1,577 Listeners

213 Listeners

300 Listeners

121 Listeners

338 Listeners

828 Listeners

174 Listeners

37 Listeners

13 Listeners

31 Listeners

10 Listeners

17 Listeners

82 Listeners

0 Listeners